Our mission, for every European Antibody Congress, is to bring you the very best speakers from big pharma, biotechs, academia and technology innovators to discuss with you the most exciting breakthroughs when it comes to the discovery and development of antibodies.
Whether that’s the newest format of a cancer killing ADC, the most advanced screening technology for mAbs, or the clinical development of a bispecific with promises to treat Alzheimer’s disease, we want to give you access to all of this to grow your knowledge, grow your business, and grow your connections.
Over 100 high profile speakers from Novartis, Roche, Pfizer, GSK, MSD, Sanofi, Genentech, Janssen and many more
have already confirmed they will unveil the technologies, development practices and value chain analysis which will help you optimise your own processes.
Taking place alongside the European Antibody Congress will be the co-located World Biosimilar Congress, World Immunotherapy Congress and HPAPI World Congress. Have access to plenty of content across the 3 days and more networking opportunities than ever before with over 500 leading industry professionals.
Fill in the form on your right to access the agenda